Literature DB >> 32437058

Folium Sennae and emodin reverse airway smooth muscle contraction.

Jun-Ying Qiu1, Li-Qun Ma1, Bei-Bei Liu1, Wen-Jing Zhang1, Meng-Su Liu1, Ge-Ge Wang1, Xiao-Xue Zhao1, Xi Luo1, Qian Wang1, Hao Xu1, Dun-An Zang1, Jinhua Shen1, Yong-Bo Peng1, Ping Zhao1, Lu Xue1, Meng-Fei Yu1, Weiwei Chen1, Jiapei Dai2, Qing-Hua Liu1.   

Abstract

The objective of this project was to find a bronchodilatory compound from herbs and clarify the mechanism. We found that the ethanol extract of Folium Sennae (EEFS) can relax airway smooth muscle (ASM). EEFS inhibited ASM contraction, induced by acetylcholine, in mouse tracheal rings and lung slices. High-performance liquid chromatography assay showed that EEFS contained emodin. Emodin had a similar reversal action. Acetylcholine-evoked contraction was also partially reduced by nifedipine (a selective inhibitor of L-type voltage-dependent Ca2+ channels, LVDCCs), YM-58483 (a selective inhibitor of store-operated Ca2+ entry, SOCE), as well as Y-27632 (an inhibitor of Rho-associated protein kinase). In addition, LVDCC- and SOCE-mediated currents and cytosolic Ca2+ elevations were inhibited by emodin. Emodin reversed acetylcholine-caused increases in phosphorylation of myosin phosphatase target subunit 1. Furthermore, emodin, in vivo, inhibited acetylcholine-induced respiratory system resistance in mice. These results indicate that EEFS-induced relaxation results from emodin inhibiting LVDCC, SOCE, and Ca2+ sensitization. These findings suggest that Folium Sennae and emodin may be new sources of bronchodilators.
© 2020 International Federation for Cell Biology.

Entities:  

Keywords:  Ca2+ sensitization; Folium Sennae; L-type voltage-dependent Ca2+ channels; emodin; respiratory system resistance; store-operated Ca2+ entry

Mesh:

Substances:

Year:  2020        PMID: 32437058     DOI: 10.1002/cbin.11393

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  1 in total

1.  Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.

Authors:  Namisha Sharma; Mehanathan Muthamilarasan; Ashish Prasad; Manoj Prasad
Journal:  Genomics       Date:  2020-07-24       Impact factor: 5.736

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.